of 03:50 PM ET 10/21/2014Latest News Headlines for VG Life Sciences IncNew Data Implicate Components of Adaptive Immunity in Traumatic Brain Injury  Monday 10/20/2014 08:07 AM ET - GlobeNewsWire via Dow Jones News  New Data Implicate Components of Adaptive Immunity in Traumatic Brain Injury   SANTA BARBARA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc., (OTCQB:VGLS) a biotechnology company, announces today that one of its scientific advisors, Dr. Richard Tobin, PhD, published data demonstrating that when there is traumatic brain injury (TBI), the body inflicts additional neural damage via the immune system. The data generated by Dr. Tobin shows immune therapy using VG Life Sciences' patented drug VG1177 can improve the condition.  VG Life Sciences Inc. Announces Upgrading to OTCQB Marketplace  Thursday 10/16/2014 06:03 PM ET - GlobeNewsWire via Dow Jones News  VG Life Sciences Inc. Announces Upgrading to OTCQB Marketplace   SANTA BARBARA, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- VG Life Sci